Services
Spravato: Proven Effective for Treatment-Resistant Depression
If you’ve taken two or more oral antidepressants and still experience symptoms of depression, you might have treatment-resistant depression (TRD). It might be time to talk to your provider about a different treatment approach. You may benefit from adding SPRAVATO® to your existing oral antidepressant if you’re an adult with major depressive disorder (MDD) who has had an inadequate response to two or more oral antidepressants, known as treatment-resistant depression (TRD). In a short-term study, more patients using SPRAVATO® plus oral antidepressant demonstrated rapid and superior reduction in depressive symptoms at four weeks compared to those who received placebo plus an oral antidepressant. Spravato is also FDA approved as a monotherapy for patients who are no longer on an antidepressant. Patients who stayed on SPRAVATO® were less likely to experience a return in depressive symptoms known as relapse).
3 Semi Private Spravato Suites
Page Health Services is a Spravato REMS certified facility. We have 3 comfortable Spravato suites where you can recline, rest, and relax during the required monitoring period. At each Spravato treatment session you must stay for two hours of monitoring and have a designated ride home. Feel free to bring personal devices, head phones, water, and/or other personal items to make your monitoring time even more comfortable.
Psychiatric Medication Management
You are your own best advocate!
We believe that patients should have an active role in developing personalized treatment plans. Your input will be listened to, respected, and valued. We consider it to be a privilege to be partners on your mental health journey.
